Brief: Trinity Biotech PLC Reports Qtrly Diluted Earnings Per ADR Of $0.09

Trinity Biotech

31/03/2020 17:41

March 31 (Reuters) - Trinity Biotech PLC  TRIB.O :
    * TRINITY BIOTECH PLC - WE ARE BEGINNING TO SEE SOME
NEGATIVE
IMPACT ON OUR REVENUES DUE TO COVID-19 PANDEMIC
    * TRINITY BIOTECH PLC - COVID-19 PANDEMIC WILL HAVE AN
IMPACT ON
OUR QUARTER 1 REVENUES AND MORE SO IN QUARTER 2
    * TRINITY BIOTECH PLC - EXPECT REVENUES TO REBOUND QUICKLY
AND FOR
THERE TO BE NO LONG TERM IMPACT
    * TRINITY BIOTECH PLC QTRLY DILUTED EARNINGS PER ADR $0.09
    * TRINITY BIOTECH PLC QTRLY REVENUE $21.3 MILLION VERSUS
$24.5
MILLION
    * TRINITY BIOTECH PLC - HAVE MADE DECISION TO CLOSE OUR
MANUFACTURING PLANT IN CARLSBAD, CALIFORNIA ON JUNE 30, 2020
    * TRINITY BIOTECH PLC - CLOSE TO COMPLETING DEVELOPMENT OF
AN
ELISA TEST FOR DETECTION OF ANTIBODIES TO THE VIRUS THAT CAUSES
COVID-19

Source text for Eikon:  ID:nNDL2scJL1 
Further company coverage:  TRIB.O 

 ((Reuters.Briefs@thomsonreuters.com;))